CytomX Therapeutics
CTMX
$1.89
Share price
-5.50%
Change (1 day)
6.78%
Change (1 year)
Categories
Operating Margin for CytomX Therapeutics (CTMX)
Operating Margin as of May 2024 (TTM): -190.61%
According to CytomX Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -190.61%. At the end of 2021 the company had an Operating Margin of -120.17%.
Operating Margin history for CytomX Therapeutics from 2015 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -120.17% | 157.73% |
| 2020 | -46.63% | -73.89% |
| 2019 | -178.58% | 51.15% |
| 2018 | -118.15% | 94.03% |
| 2017 | -60.89% | -84.45% |
| 2016 | -391.67% | -14.59% |
| 2015 | -458.56% | -23.17% |
| 2014 | -596.81% | -64.98% |
| 2013 | -1,704.17% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.